Page 2 - பல்கலைக்கழகம் ஆஃப் மாசசூசெட்ஸ் பள்ளி மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Remove the waiver requirement for buprenorphine prescribing UMass School of Medicine Specialists © Ted S. Warren A man holds his prescription for buprenorphine, a medicine that helps treat substance use disorder, as he prepares to take a dose in a clinic in Olympia, Wash. in November, 2019. Buprenorphine, otherwise known by its brand name, Suboxone, is an essential medication in the treatment of opioid addiction. Access to this therapy remains limited by a unique requirement that prescribing physicians must obtain a special waiver from the US Drug Enforcement Agency after eight hours of certified education. The original legislation, cosponsored by then-Senator Joe Biden in 2000, was focused on increasing access to opioid addiction treatment. The historical basis for this additional training rested in concerns about effectiveness, availability, and adverse health consequences of patients during the transition of opioid use disorder treatment from a methadone cl

New yorkUnited statesNew hampshireUniversity of massachusettsTeds warrenPaul tonkoMaggie hassanLisa murkowskiMaura healyJoe bidenCenters for diseaseUniversity of massachusetts school medicineUs drug enforcement agencyHuman servicesUs department of healthUmass medical school